
Centene Corporation CNC
$ 40.59
-0.66%
Annual report 2024
added 02-18-2025
Centene Corporation EV/EBITDA Ratio 2011-2025 | CNC
Annual EV/EBITDA Ratio Centene Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 26.4 | 10.6 | 12.1 | 16 | 14.3 | 7.63 | 8.4 | 10.2 | 8.49 | 29.2 | 7.94 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.2 | 7.63 | 13.7 |
EV/EBITDA Ratio of other stocks in the Health care industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
19.2 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
9.45 | $ 276.37 | 0.62 % | $ 75.7 B | ||
|
Triple-S Management Corporation
GTS
|
79.5 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
16.1 | - | -0.19 % | $ 2.49 B | ||
|
Humana
HUM
|
21.3 | $ 273.95 | 2.12 % | $ 33 B | ||
|
CVS Health Corporation
CVS
|
16.2 | $ 79.55 | 0.15 % | $ 100 B | ||
|
Molina Healthcare
MOH
|
20.4 | $ 166.33 | -1.28 % | $ 9.55 B | ||
|
UnitedHealth Group Inc.
UNH
|
21.6 | $ 340.29 | -0.45 % | $ 313 B | ||
|
NovoCure Limited
NVCR
|
-243 | $ 13.02 | -2.29 % | $ 1.4 B |